Search research articles
Contact Us
Filters
Showing results (41-50 of 71) with videos related to
Page
of 8
Sort By:
Gene Therapy
|
May 26, 2006
Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD
G McClorey, H M Moulton, P L Iversen, et al.
Oncogene
|
July 19, 2011
Inhibition of p53 expression by peptide-conjugated phosphorodiamidate morpholino oligomers sensitizes human cancer cells to chemotherapeutic drugs
W Ma, Y Lin, W Xuan, et al.
Methods in Molecular Medicine
|
March 2, 2011
Continuous infusion of antisense phosphorothioate therapeutics
P L Iversen, B L Copple, H K Tewary, et al.
Cancer Letters
|
June 24, 1997
Tumor cell growth is inhibited by suppressing metallothionein-I synthesis
A Takeda, H Hisada, S Okada, et al.
In Vitro Cellular & Developmental Biology. Animal
|
December 1, 1995
An in vitro model for endothelial permeability: assessment of monolayer integrity
P W Kazakoff, T R McGuire, E B Hoie, et al.
Toxicology and Applied Pharmacology
|
November 2, 1999
Bolus intravenous injection of phosphorothioate oligonucleotides causes hypotension by acting as alpha(1)-adrenergic receptor antagonists
P L Iversen, K G Cornish, L J Iversen, et al.
Pharmaceutical Research
|
August 26, 1998
In vivo properties of an in situ forming gel for parenteral delivery of macromolecular drugs
R Joshi, V Arora, J P Desjardins, et al.
Analytical Biochemistry
|
July 1, 1990
Preparation of 35S-labeled polyphosphorothioate oligodeoxyribonucleotides by use of hydrogen phosphonate chemistry
A Stein, P L Iversen, C Subasinghe, et al.
Molecular Pharmacology
|
June 17, 1998
Selective inhibition of alpha1B-adrenergic receptor expression and function using a phosphorothioate antisense oligodeoxynucleotide
P J Gonzalez-Cabrera, P L Iversen, M F Liu, et al.
Experimental Cell Research
|
September 30, 1999
The cytotoxic effects of single-stranded telomere mimics on OMA-BL1 cells
T J Page, J E Mata, J A Bridge, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 71) with videos related to
Sort By:
Page
of 8
Gene Therapy
|
May 26, 2006
Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD
G McClorey, H M Moulton, P L Iversen, et al.
Oncogene
|
July 19, 2011
Inhibition of p53 expression by peptide-conjugated phosphorodiamidate morpholino oligomers sensitizes human cancer cells to chemotherapeutic drugs
W Ma, Y Lin, W Xuan, et al.
Methods in Molecular Medicine
|
March 2, 2011
Continuous infusion of antisense phosphorothioate therapeutics
P L Iversen, B L Copple, H K Tewary, et al.
Cancer Letters
|
June 24, 1997
Tumor cell growth is inhibited by suppressing metallothionein-I synthesis
A Takeda, H Hisada, S Okada, et al.
In Vitro Cellular & Developmental Biology. Animal
|
December 1, 1995
An in vitro model for endothelial permeability: assessment of monolayer integrity
P W Kazakoff, T R McGuire, E B Hoie, et al.
Toxicology and Applied Pharmacology
|
November 2, 1999
Bolus intravenous injection of phosphorothioate oligonucleotides causes hypotension by acting as alpha(1)-adrenergic receptor antagonists
P L Iversen, K G Cornish, L J Iversen, et al.
Pharmaceutical Research
|
August 26, 1998
In vivo properties of an in situ forming gel for parenteral delivery of macromolecular drugs
R Joshi, V Arora, J P Desjardins, et al.
Analytical Biochemistry
|
July 1, 1990
Preparation of 35S-labeled polyphosphorothioate oligodeoxyribonucleotides by use of hydrogen phosphonate chemistry
A Stein, P L Iversen, C Subasinghe, et al.
Molecular Pharmacology
|
June 17, 1998
Selective inhibition of alpha1B-adrenergic receptor expression and function using a phosphorothioate antisense oligodeoxynucleotide
P J Gonzalez-Cabrera, P L Iversen, M F Liu, et al.
Experimental Cell Research
|
September 30, 1999
The cytotoxic effects of single-stranded telomere mimics on OMA-BL1 cells
T J Page, J E Mata, J A Bridge, et al.
Page
of 8